A phase 1 trial to evaluate an orally ingested probiotic yeast genetically modified to express a tetra-specific anti-toxin for clostridioides difficile
Active Awarded Last action
- Contract number
- 75N93025F00001
- Awardee
-
Icon Government And Public Health Solutions, Inc. UEI JHJ7HXD5XR47
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,514,022
Award facts
- Contract value 100% obligated
- $2,514,022.00 Current and potential, with all options
- Completion date 71% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Penllyn, PA 19422, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $2,143,921 | |
| Original award | $370,101 |
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to Icon Government And Public Health Solutions, Inc. on January 14, 2022, with a ceiling value of $2,514,022 under the Early Phase Clinical Trial Units (EPCTU) IDIQ to conduct a Phase 1 trial evaluating an orally ingested probiotic yeast genetically modified to express a tetra-specific anti-toxin for Clostridioides difficile.
Place of performance is Penllyn, PA. The order is priced on a cost-plus-fixed-fee basis with an ultimate completion date of September 21, 2028. No set-aside was used in the issuance.
Quick answers
Who was awarded contract 75N93025F00001?
75N93025F00001 was awarded to Icon Government And Public Health Solutions, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on January 14, 2022.
How much is contract 75N93025F00001 worth?
The government has obligated $2,514,022 on 75N93025F00001.
Is contract 75N93025F00001 an order under another contract?
Yes. 75N93025F00001 is a delivery order under 75N93022D00018, an indefinite delivery contract, on Early Phase Clinical Trial Units (EPCTU).
Was contract 75N93025F00001 competed?
The extent of competition for 75N93025F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award